相似文献
1
Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma.
Can Urol Assoc J. 2009 Feb;3(1):73-6. doi: 10.5489/cuaj.1028.
2
Blood loss and the need for transfusion in patients who undergo partial or radical nephrectomy for renal cell carcinoma.
J Urol. 2000 Oct;164(4):1160-3.
3
Partial nephrectomy in the treatment of localized renal cell carcinoma: experience of Taichung Veterans General Hospital.
J Chin Med Assoc. 2007 Jul;70(7):281-5. doi: 10.1016/S1726-4901(07)70005-9.
4
Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
J Urol. 2017 Aug;198(2):289-296. doi: 10.1016/j.juro.2017.03.012. Epub 2017 Mar 6.
5
A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma.
J Urol. 2015 Aug;194(2):297-303. doi: 10.1016/j.juro.2015.03.096. Epub 2015 Mar 23.
6
Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
Int J Urol. 2014 Apr;21(4):352-7. doi: 10.1111/iju.12283. Epub 2013 Sep 30.
7
Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
J Urol. 2005 Aug;174(2):466-72; discussion 472; quiz 801. doi: 10.1097/01.ju.0000165572.38887.da.
8
[New aspects in the treatment of localized renal cell carcinoma].
Urologe A. 2020 Feb;59(2):142-148. doi: 10.1007/s00120-019-01105-8.
9
[Survival analysis of interferon-alpha on locally advanced clear cell renal cell carcinoma after radical nephrectomy].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2012 Jan;43(1):91-4.
10
Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy.
BJU Int. 2012 May;109(10):1468-73. doi: 10.1111/j.1464-410X.2011.10531.x. Epub 2011 Aug 25.
引用本文的文献
1
Internist's tumour into thyroid: A case report.
J West Afr Coll Surg. 2024 Jul-Sep;14(3):348-351. doi: 10.4103/jwas.jwas_131_23. Epub 2024 May 24.
2
Optimal sequencing of the first- and second-line target therapies in metastatic renal cell carcinoma: based on nationally representative data analysis from the Korean National Health Insurance System.
BMC Cancer. 2023 May 30;23(1):483. doi: 10.1186/s12885-023-10991-3.
3
Protocol for the Flinders Kidney Health Registry: patient outcomes of kidney cancers and nephrectomies.
BMC Urol. 2022 Jul 21;22(1):112. doi: 10.1186/s12894-022-01065-w.
4
Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies.
World J Urol. 2022 May;40(5):1175-1183. doi: 10.1007/s00345-022-03960-1. Epub 2022 Feb 26.
5
Partial nephrectomy and positive surgical margin, oncologic outcomes and predictors: a 15-year single institution experience.
Cent European J Urol. 2021;74(4):516-522. doi: 10.5173/ceju.2021.0191. Epub 2021 Dec 6.
6
Management of colon-invading renal cell carcinoma: Operative technique and systematic review.
Urol Ann. 2021 Jan-Mar;13(1):1-8. doi: 10.4103/UA.UA_86_20. Epub 2021 Jan 19.
7
Comparative Study Assessing Postoperative Renal Loss Using Two Different Partial Nephrectomy Techniques: Off-Clamp versus Standard On-Clamp Surgery.
Curr Urol. 2020 Mar;14(1):38-43. doi: 10.1159/000499262. Epub 2020 Mar 20.
8
The impact of intra-operative cell salvage during open nephrectomy.
Asian J Urol. 2019 Oct;6(4):346-352. doi: 10.1016/j.ajur.2018.06.008. Epub 2018 Jun 27.
9
Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study.
CMAJ Open. 2017 Dec 11;5(4):E834-E841. doi: 10.9778/cmajo.20170005.
10
Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative.
Can Urol Assoc J. 2017 Jun;11(6):182-187. doi: 10.5489/cuaj.4264.
本文引用的文献
1
Renal cell carcinoma guideline.
Eur Urol. 2007 Jun;51(6):1502-10. doi: 10.1016/j.eururo.2007.03.035. Epub 2007 Mar 28.
2
A review on follow-up strategies for renal cell carcinoma after nephrectomy.
Eur Urol. 2007 Jun;51(6):1490-500; discussion 1501. doi: 10.1016/j.eururo.2006.12.031. Epub 2007 Jan 9.
3
Cancer statistics, 2006.
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
4
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
J Urol. 2006 Mar;175(3 Pt 1):864-9. doi: 10.1016/S0022-5347(05)00334-4.
5
Prognostic value of thrombocytosis in renal cell carcinoma.
J Urol. 2006 Mar;175(3 Pt 1):859-63. doi: 10.1016/S0022-5347(05)00526-4.
6
Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
J Urol. 2005 Jun;173(6):1853-62. doi: 10.1097/01.ju.0000165693.68449.c3.
7
Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma.
BJU Int. 2005 Mar;95(4):522-5. doi: 10.1111/j.1464-410X.2005.05331.x.
8
Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients.
J Urol. 2005 Feb;173(2):391-4. doi: 10.1097/01.ju.0000148951.71353.8b.
9
Multi-institutional validation of a symptom based classification for renal cell carcinoma.
J Urol. 2004 Sep;172(3):858-62. doi: 10.1097/01.ju.0000135837.64840.55.
10
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.
J Clin Oncol. 2004 Aug 15;22(16):3316-22. doi: 10.1200/JCO.2004.09.104.
Zotero 插件